Research ArticleAccepted Article
Comparing psoriatic arthritis low-field magnetic resonance imaging, ultrasound and clinical outcomes: data from the TICOPA trial
Philip S Helliwell, Laura C Coates, Ne Siang Chew, Giovanni Lettieri, Anna R Moverley, Jane E Freeston, Jackie Nam, Robin Waxman, Paul Emery and Philip G Conaghan
The Journal of Rheumatology November 2019, jrheum.181385; DOI: https://doi.org/10.3899/jrheum.181385
Philip S Helliwell
From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford UK; Bradford Teaching Hospitals Foundation Trust, Bradford, UK; York Teaching Hospitals NHS Foundation Trust, Scarborough General Hospital, Department of Rheumatology, Woodlands Drive, Scarborough, YO12 6QL. The TICOPA study was supported by Arthritis Research UK (grant no 18825) and Pfizer. This study presents independent research supported by the National Institute for Health Research (NIHR) Leeds Biomedical Research Centre (BRC). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. Address correspondence to Dr Philip Helliwell LIRMM, Chapel Allerton Hospital, Chapeltown Road Leeds LS7 4SA. Email: p.helliwell@leeds.ac.uk
Laura C Coates
From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford UK; Bradford Teaching Hospitals Foundation Trust, Bradford, UK; York Teaching Hospitals NHS Foundation Trust, Scarborough General Hospital, Department of Rheumatology, Woodlands Drive, Scarborough, YO12 6QL. The TICOPA study was supported by Arthritis Research UK (grant no 18825) and Pfizer. This study presents independent research supported by the National Institute for Health Research (NIHR) Leeds Biomedical Research Centre (BRC). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. Address correspondence to Dr Philip Helliwell LIRMM, Chapel Allerton Hospital, Chapeltown Road Leeds LS7 4SA. Email: p.helliwell@leeds.ac.uk
Ne Siang Chew
From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford UK; Bradford Teaching Hospitals Foundation Trust, Bradford, UK; York Teaching Hospitals NHS Foundation Trust, Scarborough General Hospital, Department of Rheumatology, Woodlands Drive, Scarborough, YO12 6QL. The TICOPA study was supported by Arthritis Research UK (grant no 18825) and Pfizer. This study presents independent research supported by the National Institute for Health Research (NIHR) Leeds Biomedical Research Centre (BRC). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. Address correspondence to Dr Philip Helliwell LIRMM, Chapel Allerton Hospital, Chapeltown Road Leeds LS7 4SA. Email: p.helliwell@leeds.ac.uk
Giovanni Lettieri
From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford UK; Bradford Teaching Hospitals Foundation Trust, Bradford, UK; York Teaching Hospitals NHS Foundation Trust, Scarborough General Hospital, Department of Rheumatology, Woodlands Drive, Scarborough, YO12 6QL. The TICOPA study was supported by Arthritis Research UK (grant no 18825) and Pfizer. This study presents independent research supported by the National Institute for Health Research (NIHR) Leeds Biomedical Research Centre (BRC). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. Address correspondence to Dr Philip Helliwell LIRMM, Chapel Allerton Hospital, Chapeltown Road Leeds LS7 4SA. Email: p.helliwell@leeds.ac.uk
Anna R Moverley
From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford UK; Bradford Teaching Hospitals Foundation Trust, Bradford, UK; York Teaching Hospitals NHS Foundation Trust, Scarborough General Hospital, Department of Rheumatology, Woodlands Drive, Scarborough, YO12 6QL. The TICOPA study was supported by Arthritis Research UK (grant no 18825) and Pfizer. This study presents independent research supported by the National Institute for Health Research (NIHR) Leeds Biomedical Research Centre (BRC). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. Address correspondence to Dr Philip Helliwell LIRMM, Chapel Allerton Hospital, Chapeltown Road Leeds LS7 4SA. Email: p.helliwell@leeds.ac.uk
Jane E Freeston
From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford UK; Bradford Teaching Hospitals Foundation Trust, Bradford, UK; York Teaching Hospitals NHS Foundation Trust, Scarborough General Hospital, Department of Rheumatology, Woodlands Drive, Scarborough, YO12 6QL. The TICOPA study was supported by Arthritis Research UK (grant no 18825) and Pfizer. This study presents independent research supported by the National Institute for Health Research (NIHR) Leeds Biomedical Research Centre (BRC). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. Address correspondence to Dr Philip Helliwell LIRMM, Chapel Allerton Hospital, Chapeltown Road Leeds LS7 4SA. Email: p.helliwell@leeds.ac.uk
Jackie Nam
From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford UK; Bradford Teaching Hospitals Foundation Trust, Bradford, UK; York Teaching Hospitals NHS Foundation Trust, Scarborough General Hospital, Department of Rheumatology, Woodlands Drive, Scarborough, YO12 6QL. The TICOPA study was supported by Arthritis Research UK (grant no 18825) and Pfizer. This study presents independent research supported by the National Institute for Health Research (NIHR) Leeds Biomedical Research Centre (BRC). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. Address correspondence to Dr Philip Helliwell LIRMM, Chapel Allerton Hospital, Chapeltown Road Leeds LS7 4SA. Email: p.helliwell@leeds.ac.uk
Robin Waxman
From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford UK; Bradford Teaching Hospitals Foundation Trust, Bradford, UK; York Teaching Hospitals NHS Foundation Trust, Scarborough General Hospital, Department of Rheumatology, Woodlands Drive, Scarborough, YO12 6QL. The TICOPA study was supported by Arthritis Research UK (grant no 18825) and Pfizer. This study presents independent research supported by the National Institute for Health Research (NIHR) Leeds Biomedical Research Centre (BRC). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. Address correspondence to Dr Philip Helliwell LIRMM, Chapel Allerton Hospital, Chapeltown Road Leeds LS7 4SA. Email: p.helliwell@leeds.ac.uk
Paul Emery
From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford UK; Bradford Teaching Hospitals Foundation Trust, Bradford, UK; York Teaching Hospitals NHS Foundation Trust, Scarborough General Hospital, Department of Rheumatology, Woodlands Drive, Scarborough, YO12 6QL. The TICOPA study was supported by Arthritis Research UK (grant no 18825) and Pfizer. This study presents independent research supported by the National Institute for Health Research (NIHR) Leeds Biomedical Research Centre (BRC). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. Address correspondence to Dr Philip Helliwell LIRMM, Chapel Allerton Hospital, Chapeltown Road Leeds LS7 4SA. Email: p.helliwell@leeds.ac.uk
Philip G Conaghan
From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford UK; Bradford Teaching Hospitals Foundation Trust, Bradford, UK; York Teaching Hospitals NHS Foundation Trust, Scarborough General Hospital, Department of Rheumatology, Woodlands Drive, Scarborough, YO12 6QL. The TICOPA study was supported by Arthritis Research UK (grant no 18825) and Pfizer. This study presents independent research supported by the National Institute for Health Research (NIHR) Leeds Biomedical Research Centre (BRC). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. Address correspondence to Dr Philip Helliwell LIRMM, Chapel Allerton Hospital, Chapeltown Road Leeds LS7 4SA. Email: p.helliwell@leeds.ac.uk
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Accepted manuscript
Comparing psoriatic arthritis low-field magnetic resonance imaging, ultrasound and clinical outcomes: data from the TICOPA trial
Philip S Helliwell, Laura C Coates, Ne Siang Chew, Giovanni Lettieri, Anna R Moverley, Jane E Freeston, Jackie Nam, Robin Waxman, Paul Emery, Philip G Conaghan
The Journal of Rheumatology Nov 2019, jrheum.181385; DOI: 10.3899/jrheum.181385
Accepted manuscript
Comparing psoriatic arthritis low-field magnetic resonance imaging, ultrasound and clinical outcomes: data from the TICOPA trial
Philip S Helliwell, Laura C Coates, Ne Siang Chew, Giovanni Lettieri, Anna R Moverley, Jane E Freeston, Jackie Nam, Robin Waxman, Paul Emery, Philip G Conaghan
The Journal of Rheumatology Nov 2019, jrheum.181385; DOI: 10.3899/jrheum.181385